Skip to main content

Mechanism-based engineering against anthracycline cardiotoxicity.

Publication ,  Journal Article
Force, T; Wang, Y
Published in: Circulation
July 9, 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 9, 2013

Volume

128

Issue

2

Start / End Page

98 / 100

Location

United States

Related Subject Headings

  • Neuregulin-1
  • Myocytes, Cardiac
  • Male
  • Humans
  • Female
  • Doxorubicin
  • Chemical Engineering
  • Cardiovascular System & Hematology
  • Cardiotonic Agents
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Force, T., & Wang, Y. (2013). Mechanism-based engineering against anthracycline cardiotoxicity. Circulation, 128(2), 98–100. https://doi.org/10.1161/CIRCULATIONAHA.113.003688
Force, Thomas, and Yibin Wang. “Mechanism-based engineering against anthracycline cardiotoxicity.Circulation 128, no. 2 (July 9, 2013): 98–100. https://doi.org/10.1161/CIRCULATIONAHA.113.003688.
Force T, Wang Y. Mechanism-based engineering against anthracycline cardiotoxicity. Circulation. 2013 Jul 9;128(2):98–100.
Force, Thomas, and Yibin Wang. “Mechanism-based engineering against anthracycline cardiotoxicity.Circulation, vol. 128, no. 2, July 2013, pp. 98–100. Pubmed, doi:10.1161/CIRCULATIONAHA.113.003688.
Force T, Wang Y. Mechanism-based engineering against anthracycline cardiotoxicity. Circulation. 2013 Jul 9;128(2):98–100.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 9, 2013

Volume

128

Issue

2

Start / End Page

98 / 100

Location

United States

Related Subject Headings

  • Neuregulin-1
  • Myocytes, Cardiac
  • Male
  • Humans
  • Female
  • Doxorubicin
  • Chemical Engineering
  • Cardiovascular System & Hematology
  • Cardiotonic Agents
  • Animals